Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Perspect Psychiatr Care. 2013 Jan 18;49(4):226–234. doi: 10.1111/ppc.12008

Table 3.

Medication Taken by Participants (n = 9) who Began IPSRT-G as a Percentage of the Sample (no. in parentheses), Mean Dose and Range

Medication % (no.) Dose in Milligrams M(SD) Dose Range in Milligrams
Mood Stabilizer
 divalproex sodium 33% (3) 1000 (433.01) 750–1500
 lamotrigine 44% (4) 181.25 (114.33) 25–300
 lithium 33% (3) 1000 (0) 900–1200
Antianxiety
 alprazolam 11% (1) 1 (0) 1
 clonazepam 22 % (2) 1.75 (1.76) 0.5–3
 lorazepam 22% (2) 2 (1.41) 1–3
Antipsychotic
 aripiprazole 11% (1) 2 (0) 2
 olanzapine 11% (1) 10 (0) 10
 quetiapine 11% (1) 350 (0) 350
Antidepressant
 bupropion 11% (1) 150 (0) 150
 amitriptyline 11% (1) 25 (0) 25
 fluoxetine 11% (1) 40 (0) 40
 sertraline 11% (1) 100 (0) 100
 trazodone 22% (2) 125 (35.35) 100–200
 venlafaxine 11% (1) 112.5 (0) 112.5